British kindred with dominant FMF associated with high incidence of AA amyloidosis caused by novel MEFV variant, and a review of the literature.

OBJECTIVES Hereditary systemic autoinflammatory diseases are rare genetic disorders, which if untreated, can be complicated by AA amyloidosis leading to renal failure and premature death. Our objective was to find a genetic cause in a British family with a dominantly inherited autoinflammatory disease complicated by AA amyloidosis. METHODS The index patient and his sister underwent comprehensive clinical and laboratory assessment including the next-generation sequencing panel targeting autoinflammatory genes. Subsequently, other relatives underwent clinical evaluation and genetic testing. Screening of the SAA1 gene was performed in all symptomatic cases. RESULTS The index case and his sister presented with proteinuria due to AA amyloidosis. They have been suffering from episodes of fever accompanied by severe abdominal and chest pain, arthritis and erythema since childhood. Their father died aged 52 years from complications following a cadaveric renal transplantation. The post-mortem examination demonstrated AA amyloidosis. The index case's grandmother, two paternal cousins and two of their children described similar symptoms. All symptomatic individuals had excellent responses to colchicine. Next-generation sequencing analysis identified a single MEFV p.P373L variant in the index case, his sister and subsequently, in symptomatic family members. Sequencing of the SAA1 gene revealed all cases were heterozygous for the SAA1.1 allele. CONCLUSION Typically FMF is an autosomal recessive disorder; nonetheless rare cases of dominantly inherited disease have previously been described. Here we report a novel MEFV variant p.P373L, causing dominant FMF complicated by AA amyloidosis in four generations of a British family.

[1]  D. Kastner,et al.  Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study , 2018, Annals of the rheumatic diseases.

[2]  Helena Ahlfors,et al.  Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis , 2017, PloS one.

[3]  P. Hawkins,et al.  Autosomal dominant familial Mediterranean fever in Northern European Caucasians associated with deletion of p.M694 residue—a case series and genetic exploration , 2017, Rheumatology.

[4]  H. Hirata,et al.  Three Japanese patients (mother and two children) with familial Mediterranean fever associated with compound heterozygosity for L110P/E148Q/M694I and an autosomal true dominant inheritance pattern. , 2013, Asian Pacific journal of allergy and immunology.

[5]  C. Wijmenga,et al.  MEFV mutations affecting pyrin amino acid 577 cause autosomal dominant autoinflammatory disease , 2013, Annals of the rheumatic diseases.

[6]  D. Kastner,et al.  Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice. , 2011, Immunity.

[7]  J. Hugot,et al.  Infevers: An evolving mutation database for auto‐inflammatory syndromes , 2004, Human mutation.

[8]  D. Booth,et al.  The genetic basis of autosomal dominant familial Mediterranean fever. , 2000, QJM : monthly journal of the Association of Physicians.

[9]  D. Booth,et al.  SAA1 alleles as risk factors in reactive systemic AA amyloidosis. , 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[10]  Jacques Demaille,et al.  A candidate gene for familial Mediterranean fever , 1997, Nature Genetics.

[11]  F. Collins,et al.  Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean Fever , 1997, Cell.

[12]  M. Pepys,et al.  Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component. , 1990, The New England journal of medicine.

[13]  D. Zemer,et al.  Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. , 1986, The New England journal of medicine.

[14]  S. Goldfinger Colchicine for familial Mediterranean fever. , 1972, The New England journal of medicine.

[15]  H. Puchtler,et al.  ON THE BINDING OF CONGO RED BY AMYLOID , 1962 .

[16]  H. Reimann,et al.  Periodic peritonitis; heredity and pathology: report of seventy-two cases. , 1954, Journal of the American Medical Association.

[17]  J. Yagüe,et al.  A severe autosomal‐dominant periodic inflammatory disorder with renal AA amyloidosis and colchicine resistance associated to the MEFV H478Y variant in a Spanish kindred: An unusual familial Mediterranean fever phenotype or another MEFV‐associated periodic inflammatory disorder? , 2004, American journal of medical genetics. Part A.

[18]  M. Tekin,et al.  Genotype-phenotype correlation in a large group of Turkish patients with familial mediterranean fever: evidence for mutation-independent amyloidosis. , 2000, Rheumatology.

[19]  M. Pras,et al.  MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. , 1999, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[20]  D. Zemer,et al.  Variable incidence of amyloidosis in familial Mediterranean fever among different ethnic groups. , 1982, The Johns Hopkins medical journal.